Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 4Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Thrombocytopenia 1Retinal Diseases 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Myasthenia Gravis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid 1Hodgkin Disease 1Graft vs Host Disease 1Congenital Abnormalities 1Anemia 1

Interventions

venetoclax 3Imatinib Mesylate 3ponatinib 2nilotinib 2Dasatinib 2Azacitidine 2zileuton 1thymoglobulin 1pulrodemstat besilate 1posaconazole 1emvododstat 1Transplantation 1Standard of Care 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Lenalidomide 1IMC-EB10 1Homoharringtonine 1HhAntag691 1Hematopoietic Stem Cell Transplantation 1Decitabine 1Cytarabine 1Cyclosporine 1CC 401 1BID protein, human 1Antilymphocyte Serum 1AVE9633 13-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid × Hematopoietic Stem Cell Transplantation × Clear all
NCT00568633 2019-09-24

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Stanford University

Phase 3 Terminated
58 enrolled 18 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡